Prenatal Haptonomy-Based Support

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorHilal Özbek

About this trial

This study is a three-arm randomized controlled trial to be conducted among pregnant women attending the antenatal outpatient clinic of Tokat Gaziosmanpaşa University Hospital who meet the inclusion criteria. Data will be collected between April 1, 2026, and April 30, 2027.

Eligible participants will be informed about the study objectives, procedures, potential benefits and risks, and voluntary participation principles. Written informed consent will be obtained prior to enrollment. Participant confidentiality will be ensured in accordance with data protection regulations, and unique identification codes will be assigned.

At baseline (T0), participants will complete the Personal Information Form, Prenatal Attachment Inventory (PAI), and Spousal Support Scale (SSS). Following baseline assessment, participants will be randomly allocated into one of three groups:

Partner-supported haptonomy group Mother-supported haptonomy group Midwife-supported haptonomy group The haptonomy-based intervention will be delivered once weekly for three consecutive weeks in a hospital-based setting. Each session will last approximately 30 minutes and will follow a standardized protocol including structured affective touch, body awareness facilitation, emotional observation, and structured session closure. All sessions will be conducted by a research assistant who completed the Prenatal Haptonomy Instructor Training (January 29-31, 2026). The principal investigator will supervise and monitor the scientific integrity of the study.

Outcome assessments will be conducted at three time points:

T0 (Baseline): Prior to intervention T1 (Post-session 1): 24-48 hours after the first haptonomy session T2 (Post-intervention): 24-48 hours after the third haptonomy session The Prenatal Attachment Inventory and Spousal Support Scale will be re-administered at T1 and T2. Data completeness will be checked after each assessment.

Eligibility criteria

Qualifiers

Pregnant women aged 18-45 years

Attending antenatal follow-up at Tokat Gaziosmanpaşa University Hospital

Gestational age between 20 and 32 weeks

Ability to communicate in Turkish

Disqualifiers

High-risk pregnancy (e.g., preeclampsia, placenta previa, gestational diabetes requiring insulin)

Diagnosed psychiatric disorder

Multiple pregnancy

Known fetal anomaly

Trial design

Treatments tested in this trial

  • Prenatal Haptonomy-Based Support
  • Mother-Supported Haptonomy Group
  • Midwife-Supported Haptonomy Group

Treatment groups

36 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Hilal Özbek

Lead sponsor

Tokat Gaziosmanpasa University

Sponsor institution